Anthem Biosciences IPO Receives 7.51 Times Subscription Applications by Start of Day 3

Mumbai, 16 July 2025: The public issue of Anthem Biosciences IPO has received 7.51 times subscription applications by 11:19 AM on Day 3 of bidding. The IPO, which opened on 14 July 2025, is set to close by 5 PM today.

QIB and NII Response Lifts Overall Subscription

As of the latest update, Qualified Institutional Buyers (QIBs) have subscribed 4.31 times their allocated portion, highlighting notable interest from institutional players. However, the most remarkable traction has come from the Non-Institutional Investor (NII) segment, where the issue has been subscribed an exceptional 21.60 times.

Within the NII category:

• bNII (investors bidding over ₹10 lakh) clocked 24.34 times subscription
• sNII (bids below ₹10 lakh) reached 16.13 times

This surge in high-value bids underscores strong demand from wealthy individuals and corporate investors.

Retail Participation Crosses 3 Times Amid Broad-Based Interest

Retail investors have also actively participated, with the retail portion subscribed 3.33 times. This level of subscription is particularly notable given the issue’s scale and indicates a high degree of public confidence in Anthem’s business fundamentals.

Meanwhile, the employee quota has received a 3.78 times subscription, showing strong support from within the organisation.

Anchor Book Fully Subscribed Before IPO Launch

Ahead of the public issue, the anchor investor segment saw a full subscription of 1,78,24,999 shares, raising ₹1,016.02 crore. This pre-IPO support served as a positive indicator, setting the tone for the subsequent investor interest.

Subscription Momentum Builds Day by Day

Anthem Biosciences’ IPO witnessed consistent and rising interest over the three bidding days:

• Day 1 (14 July 2025): Overall subscription stood at 0.77 times
• Day 2 (15 July 2025): The issue surged to 3.48 times
• Day 3 (16 July 2025, till 11:19 AM): Subscriptions peaked at 7.51 times

With several hours still remaining before the close of bidding today, final figures are expected to rise further, driven by last-minute investor participation.

IPO Timeline: Listing Scheduled for July 21

The IPO will close at 5 PM on 16 July 2025, after which the allotment process will begin:

• Allotment Finalisation: 17 July 2025
• Refunds Initiation & Credit of Shares: 18 July 2025
• Listing on BSE & NSE: 21 July 2025

Investors are required to confirm UPI mandates by the cut-off time of 5 PM today to ensure their bids are considered.

IPO Structure and Offer Details

Anthem Biosciences IPO comprises a total public issue of 7.74 crore equity shares, raising ₹4,411.82 crore at the upper end of the price band. The allocation across categories is as follows:

• Retail Investors: 2.07 crore shares
• QIBs: 2.97 crore shares
• NIIs: 89.12 lakh shares
• Employees: 1.58 lakh shares
• Anchor Investors: 1.78 crore shares

With overwhelming interest across all investor classes and a strong anchor backing, Anthem Biosciences is poised for a high-impact debut on the stock exchanges. The IPO’s strong performance is expected to reinforce investor confidence in India’s evolving biotech sector

Disclaimer:  At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations